Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-Infected Persons: AIDS Clinical Trials Group Study A5309s

Drugs in R and D - United Kingdom
doi 10.1007/s40268-017-0205-9
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Relevance of Drug Interactions in HIV-Infected Patients Receiving Antiretroviral Therapy

2011English

Dynamic Analysis of Th1/Th2 Cytokine Concentration During Antiretroviral Therapy of HIV-1/HCV Co-Infected Patients

BMC Infectious Diseases
Infectious Diseases
2012English

Correction of Metabolic Disorders in Patients Co-Infected With HIV/HCV

ScienceRise
2015English

Changes of Body Immunity and Inflammatory Response in HIV/HCV Co-Infected Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Interactions and the Antiretroviral Therapy Adherence Among People Living With Hiv/Aids

REME: Revista Mineira de Enfermagem
2017English

An Ethical Dilemma: Availability of Antiretroviral Therapy After Clinical Trials With Hiv Infected Patients Are Ended

BMJ
1997English

Characteristics and Outcomes of Antiretroviral-Treated HIV-HBV Co-Infected Patients in Canada?

BMC Infectious Diseases
Infectious Diseases
2019English

Individualized Texting for Adherence Building (iTAB): Improving Antiretroviral Dose Timing Among HIV-Infected Persons With Co-Occurring Bipolar Disorder

AIDS and Behavior
EnvironmentalPublic HealthInfectious DiseasesSocial PsychologyOccupational Health
2014English

How Researchers Define Vulnerable Populations in HIV/AIDS Clinical Trials

AIDS and Behavior
EnvironmentalPublic HealthInfectious DiseasesSocial PsychologyOccupational Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy